Valuation : Vitrolife AB

Market Cap 12.47B 1.3B 1.12B 1.05B 960M 1.8B 124B 1.8B 4.82B 63.2B 4.88B 4.78B 201B P/E 2026 *
25.3x
P/E 2027 * 20.5x
Enterprise Value 13.02B 1.36B 1.17B 1.1B 1B 1.88B 129B 1.88B 5.03B 65.98B 5.1B 4.99B 210B EV / Sales 2026 *
3.77x
EV / Sales 2027 * 3.36x
Free-Float
54.39%
Yield 2026 *
1.2%
Yield 2027 * 1.37%
1 day-0.65%
1 week-2.44%
Current month-2.90%
1 month+2.33%
3 months-5.54%
6 months-1.66%
Current year-32.77%
1 week 91.05
Extreme 91.05
96.7
1 month 87
Extreme 87
98.1
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
153.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 31/07/2023
Director of Finance/CFO 55 09/10/2025
Chief Investment Officer 40 -
Director TitleAgeSince
Director/Board Member 63 18/04/2013
Chairman 70 31/07/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap. Importance
06/02/26 Buy

Chief Operating Officer

6,470 0.0048%
06/02/26 Buy

Chief Executive Officer

3,013 0.0022%
04/02/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%-2.44%-32.72%-31.63% 1.31B
+1.12%-0.99%+170.56%+382.74% 21.6B
-0.49%-5.41%-37.05%-22.13% 9.86B
+2.58%+12.19%+383.06%+42.08% 8.55B
-3.18%-3.03%-30.97% - 7.01B
+0.26%-0.18%+87.77%+51.66% 6.56B
-1.42%-3.08%-27.94%-20.49% 5.84B
+0.52%-2.43%-9.76%-19.44% 4.24B
-2.77%-5.58%+65.48%+79.79% 4.2B
-0.53%-3.11%-24.32%-30.15% 2.74B
Average -0.46%-1.00%+54.41%+48.05% 7.19B
Weighted average by Cap. +0.01%-0.89%+96.13%+134.95%

Financials

2026 *2027 *
Net sales 3.46B 361M 310M 292M 266M 498M 34.31B 500M 1.34B 17.52B 1.35B 1.32B 55.74B 3.71B 387M 332M 313M 285M 534M 36.79B 536M 1.43B 18.78B 1.45B 1.42B 59.76B
Net income 493M 51.38M 44.15M 41.6M 37.92M 70.94M 4.89B 71.21M 190M 2.5B 193M 189M 7.94B 609M 63.5M 54.56M 51.42M 46.86M 87.68M 6.04B 88.02M 235M 3.08B 238M 233M 9.81B
Net Debt 549M 57.28M 49.21M 46.37M 42.27M 79.08M 5.45B 79.39M 212M 2.78B 215M 210M 8.85B -26.74M -2.79M -2.4M -2.26M -2.06M -3.85M -265M -3.87M -10.33M -135M -10.47M -10.24M -431M
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
09/09/26 SEK 92.10 -0.65% 191,110
08/09/26 SEK 92.70 -0.86% 94,641
07/09/26 SEK 93.50 -1.58% 80,617
04/09/26 SEK 95.00 -1.50% 70,182
03/09/26 SEK 96.45 +2.01% 268,907
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
92.10SEK
Average target price
129.60SEK
Spread / Average Target
+40.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!